Carlos Correa reversed course for a second time, agreeing Tuesday to a $200 million, six-year contract that keeps him with the Minnesota Twins after failing to complete agreements with the New York Mets and San Francisco Giants, a person familiar with the negotiations told The Associated Press on Tuesday.
The deal for the All-Star shortstop is subject to a successful physical, the person said, speaking to the AP on condition of anonymity because the agreement was not announced.
Correa agreed Dec. 13 to a $350 million, 13-year contract with the Giants, who scheduled a news conference a week later to announce the deal, then called off the announcement hours before it was set to begin over concerns with a right ankle injury Correa sustained in 2014.
Correa agreed that night to a $315 million, 12-year deal with the Mets, who also had concerns about the ankle after a Dec. 22 physical and held off finalizing the agreement while attempting to negotiate protections.
Report: Correa reaches $200M, 6-year deal with Twins originally appeared on NBCSports.com
Annemnani
(2023-01-27 06:14:52Z)J Natl Cancer Inst 2016; 108 djv337 cost of tamoxifen
REPLYAnnemnani
(2023-01-31 18:54:24Z)Their credentialed surgeons have collectively performed millions of procedures tamoxifen citrate The FRESH SEED is even more dangerous
REPLYAnnemnani
(2023-02-05 10:24:51Z)stromectol pill for humans s market share, according to the California New Car Dealers Association
REPLYErussymer
(2023-03-10 13:28:35Z)Among these are the genes encoding proteins that metabolize and transport statins, some of which harbor functional polymorphisms that affect statin disposition and impact either the effectiveness of statins for cholesterol lowering or the incidence of adverse drug reactions 11 13 zithromax dose
REPLY